Questions surround AstraZeneca vaccine use for elderly : vim

Questions surround AstraZeneca vaccine use for elderly
AFP
2/1/2021
AFP
© Joe Giddens
The AstraZeneca vaccine was shown in clinical trials to be 62 percent effective in preventing Covid-19
The subject of a sometimes acrimonious row between the EU and Britain, the AstraZeneca Covid-19 vaccine has also fuelled debate over its effectiveness among the elderly.
Although the European Medicines Agency recommended the vaccine for adults of all ages last week, several countries have advised against administering the jab to older people.
Germany has already said it will not advise over 65s to get it.
Italy's medicines agency on Saturday approved the vaccine for all adults but recommended alternatives for people aged over 55.

Related Keywords

Italy , Germany , Sweden , United Kingdom , Poland , France , Polish , Britain , French , Joe Giddens , Eric Caumes , Astrazeneca Covid , Michal Dworczyk , John Bell , Peter English , Astrazeneca , European Medicines Agency , Oxford University , Developers Astrazeneca , Joe Giddens The Astrazeneca , President Emmanuel Macron , இத்தாலி , ஜெர்மனி , ஸ்வீடந் , ஒன்றுபட்டது கிஂக்டம் , போல்யாஂட் , பிரான்ஸ் , போலீஷ , பிரிட்டன் , பிரஞ்சு , ஓஹோ கிடென்ஸ் , ஜான் மணி , பீட்டர் ஆங்கிலம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ப்ரெஸிடெஂட் இம்மானுவேல் மேக்ரான் ,